Tackling emerging infections and future pandemic threats

The world's first end-to-end response to pandemics

Established in 2021, The Pandemic Institute is a unique collaboration of academic, health and civic partners in Liverpool with extensive national and international collaborations. The Pandemic Institute builds on Liverpool’s work leading the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (since 2014) which was at the forefront of the UK research response to Ebola, Zika and Covid-19.

Launched with an initial donation of £10m in 2021, within 18 months The Pandemic Institute raised £25m in philanthropic, commercial and UK government support, with a target of £250m by 2026. The Pandemic Institute investigators have research income from UK Research and Innovation (UKRI), the NIHR, Wellcome, Gates Foundation, and other funders.

Download our latest brochure

Find out about the latest work of The Pandemic Institute and our future priorities
Download the brochure

Our priorities

  • Accelerate global response

    • Develop globally connected, digitally enabled infrastructure to support front line scientific endeavor.
    • Next generation innovation to support in-field sampling and rapid real-time analysis.
    • Build critical mass of expertise and develop a pipeline of future leaders in pandemic and infection control.
    • Involve local, global communities in the development of response action plans.

  • Unify global intelligence

    • Facilitate a network of globally leading experts to create, develop and share real-time analytics and solutions.
    • Enable clinical and pragmatic trials to be delivered faster, smarter and with greater impact.
    • Provide transparent and openly available data for the purposes of cross-sector collaboration.
    • Enhance capacity, capability and create Centers of Excellence.

  • Increase global societal impact

    • Increase community participation in early stage trials of new diagnostics and therapeutics.
    • Develop policy with national and international impact.
    • Support community led innovation and first time entrepreneurs to create sector growth.
    • Drive international export and sharing of IP, knowledge and know-how.